AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

AstraZeneca's inhaled rescue medication, Airsupra (albuterol/budesonide), has shown significant efficacy in reducing the risk ...

The phase 3b BATURA study showed Airsupra (albuterol/budesonide) achieved a statistically significant reduction in the risk of severe asthma exacerbations when used as needed for rescue therapy ...

Airsupra is an FDA-approved combination inhaler containing albuterol and budesonide to treat asthma. But what does this prescription medication ... Uninsured patients can use various discounts to ...

announced in a press release on Sept. 17, 2024 that Phillips Medisize, which Molex acquired in 2016, had entered into an agreement to acquire Vectura Group Limited, a contract development and ...

"Combining the strengths of Phillips-Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical ...